No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Excelsior Biopharma Inc., established in 1988 and headquartered in Taipei, Taiwan, functions as a pharmaceutical enterprise with a global market presence, encompassing Taiwan, China, and other international regions. The company offers a comprehensive range of healthcare solutions, including prescription and over-the-counter medications, medical devices, nutritional supplements, and various medical supplies. Excelsior addresses numerous therapeutic areas such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, otorhinolaryngology, and infectious disease management. Its product line also features specialized diagnostic kits under the Actim brand for identifying conditions like influenza virus, fecal occult blood, acute pancreatitis, and for assessing preterm or full-week delivery and early membrane rupture. Moreover, the company provides oral hygiene products, including toothpaste, mouthwash, and gels, under the Oral7 name. Beyond product sales, Excelsior is involved in the import and export of active pharmaceutical ingredients, as well as engaging in technological research, facilitating pharmaceutical technology transfer, and participating in collaborative development and improvement initiatives. The company adopted its current name, Excelsior Biopharma Inc., in June 2003, having previously been known as Excelsior Enterprise Co., Ltd.
www.excelsiorgroup.com.twNo one on the platform currently holds 6496.TWO.
No tracked institution reports a position in 6496.TWO as of their last filing.
No one on the platform has traded 6496.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 6496.TWOExcelsior Biopharma Inc. | $24.45 | -0.81% | $1.1B | — |
| 4127.TWOTien Liang BioTech Co., Ltd. | $59.60 | -0.33% | $2.7B | — |
| 4150.TWOUnicon Optical Co., Ltd. | $1.59 | -11.67% | $234M | — |
| 4171.TWOGeneReach Biotechnology Corp. | $16.50 | +1.23% | $945M | — |
| 4194.TWOHoly Stone Healthcare Co., Ltd. | $7.35 | -0.14% | $1.1B | — |
| 6539.TWODV Biomed Co., Ltd. | $40.65 | +0.25% | $990M | — |
| 6645.TWKim Forest Enterprise Co., Ltd. | $12.50 | -1.19% | $758M | — |
Source: Financial Modeling Prep · peers by sector/industry